Personalized care has become central in Type 2 Diabetes Mellitus ( T2DM ) management, particularly with the advent of SGLT2i + DPP4i combination therapies. 1,2 Addressing the need for deeper clinical understanding, Boehringer Ingelheim invites healthcare professionals to an upcoming interactive expert session focused on evolving best practices, evidence, and long-term outcomes in T2DM care. Join us for a dynamic session featuring leading national and international experts who will provide actionable insights and address queries in our “ Ask the Experts: Personalized T2DM Care with SGLT2i + DPP4i Combinations"- bringing together renowned clinical leaders on Tuesday, 23rd September 2025 , from 2:00 PM to 3:15 PM IST .
Join our eminent speakers Dr. Mark Cooper and Padma Shri Dr. V Mohan , to discuss: Gain evidence-based, practical insights on individualizing T2DM care using SGLT2i +…